Nephron Research LLC (@NephronResearch) header
Nephron Research LLC (@NephronResearch) profile picture

Nephron Research LLC

@NephronResearch

Essential to our clients' investment process via the production of insightful research, impactful financial analyses, and innovative corporate access

nephronresearch.com
Joined October 2017
  • Tweets95
  • Following82
  • Followers526
62Media
Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)Photo by Nephron Research LLC (@NephronResearch)
Nephron Research LLC retweeted
Sofia Guerra (@SofiaGuerraR) profile picture
Sofia Guerra@SofiaGuerraR27 Oct 2022
@Farzad_MD @stephenkraus @BessemerVP @NephronResearch #digitalhealth #ValueBasedCare #Benchmarks #healthTech
2
5
Nephron Research LLC retweeted
Substantive Research (@substantiveSM) profile picture
Substantive Research@substantiveSM27 Jan 2022
Excited to announce the results of our latest analyst mapping report: the research "Brain Drain" has stabilised and brokers that reversed the research brain drain in 2021 are reaping the rewards substantiveresearch.com/matt…
Image from Substantive Research (@substantiveSM)
1
1
1
Nephron Research LLC retweeted
Drug Channels (@DrugChannels) profile picture
Drug Channels
@DrugChannels10 Feb 2021
Wow. @IQVIA_US / @NephronResearch project massive growth in #340B drugch.nl/3cU3lhp Purchases at #WAC list price to more than double from 2017 to 2021, to $96 billion (~13-14% of total U.S. #drug market) Astounding. Time for proper regulations, don't ya think?
Image from Drug Channels (@DrugChannels)
6
7
Nephron Research LLC retweeted
Andy Slavitt (@ASlavitt) profile picture
Andy Slavitt
@ASlavitt14 Jun 2020
BREAKING June 14 COVID Update: The first verdict in the May state openings is in. It paints an abundantly clear picture & it’s not good. Thanks to Nephron’s health care research team and Josh Raskin. Follow here if interested in the results.
129
2,838
268
8,477
Nephron Research LLC retweeted
Drug Channels (@DrugChannels) profile picture
Drug Channels
@DrugChannels17 Jun 2020
Big news per @NephronResearch report: @CVSHealth $CVS will launch a new #GPO called ZINC Goal: "rebate profit protection" by shifting discounts to "less transparent admin, data, compliance and other fee structures that are more difficult for #PBM customers to audit" 👇
Image from Drug Channels (@DrugChannels)
6
13
7
26
Healthcare polls last. Below oil and gas. We have work to do. Lots to do. ⁦@NephronResearch⁩ ⁦@ThinkRevive⁩ #jpretreat2020
Image from Dr. Megan Ann Greenfield (@magreenfield)
1
2
2
4
Nephron Research LLC retweeted
Jarrard Inc. (@JarrardInc) profile picture
Jarrard Inc.@JarrardInc30 Jan 2018
"We couldn’t have had more political rhetoric and regulatory scrutiny around #drug pricing – and literally nothing happened.” - @NephronResearch's Joshua Raskin. jarrardinc.com/high-stakes/2…
Image from Jarrard Inc. (@JarrardInc)
2
1
Nephron Research LLC retweeted
Jarrard Inc. (@JarrardInc) profile picture
Jarrard Inc.@JarrardInc25 Jan 2018
“It’s hard to imagine #transparency helping anyone from a pricing perspective,” says @NephronResearch’s Joshua Raskin. “If individuals are going to be armed with the actual data around cost and #quality, you’re going to see market share shift.” @NashHCC #wallstreet on #healthcare
Image from Jarrard Inc. (@JarrardInc)
1
1
Load more